Hexagon Nutrition's initial public offering (IPO) is set to list on the stock exchanges today, June 12, 2026. Investors are keenly watching the grey market premium (GMP) and the expected listing price on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE).
IPO Listing Details
The company's shares are expected to debut at a premium over the issue price, driven by strong demand from retail and institutional investors. The IPO, which was open for subscription from June 6 to June 10, received an overwhelming response, with overall subscription exceeding 50 times.
Grey Market Premium (GMP)
As of today, the GMP for Hexagon Nutrition is hovering around Rs 120-130, indicating a listing gain of approximately 25-30% over the issue price of Rs 480 per share. However, GMP is not an official indicator and can fluctuate based on market sentiment.
Listing Price Expectations
Analysts expect the stock to list at around Rs 600-610 on the NSE and BSE, providing a healthy return for investors who were allotted shares. The final listing price will be determined by market dynamics and demand during the pre-open session.
Company Overview
Hexagon Nutrition is a leading player in the nutrition and health supplements industry, offering a wide range of products catering to various health needs. The company has shown consistent growth in revenue and profitability, making it an attractive investment option.
Financial Performance
In the fiscal year 2025-26, Hexagon Nutrition reported a revenue of Rs 1,200 crore, with a net profit of Rs 180 crore. The company's strong financials and market position have bolstered investor confidence.
What Investors Should Know
Investors who have been allotted shares are advised to monitor the listing price closely and consider their exit strategy based on their investment goals. Long-term investors may hold the stock, given the company's growth prospects, while short-term traders may book profits on listing gains.
The IPO listing will be a key event for the primary market, reflecting the overall investor sentiment towards the healthcare and nutrition sector.
